Results of a national survey among Dutch surgeons treating patients with colorectal carcinoma. Current opinion about follow‐up, treatment of metastasis, and reasons to revise follow‐up practice

Grossmann, I; Bock, de Truuske; Velde, Cornelis J.H. van de; Kievit, J.; Wiggers, Theo

doi:10.1111/j.1463-1318.2007.01303.x

Cited by 29 publications

(22 citation statements)

References 41 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although the response rate was not optimal, it is comparable to prior reported web based surveys to professionals 20 . Possibly the response to web based surveys is lower than mailed surveys 2,21 , because of the anonymity.…”

Section: Professionals' Demographicssupporting

confidence: 66%

Professionals’ opinion on follow-up in breast cancer patients; perceived purpose and influence of patients’ risk factors

Hezewijk

Hille

Scholten

et al. 2011

European Journal of Surgical Oncology (EJSO)

View full text Add to dashboard Cite

This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. Design: A 29-item questionnaire on professionals' demographics, current practice, opinion on the current guideline, preferences in frequency and duration of tailored followup, and the purpose and perceived effects of follow-up was sent to 633 Dutch professionals.Results: The current national guideline is followed by 81% of respondents. All different specialists are involved in follow-up. Sixty-nine percent of respondents' report nurse practitioners to be involved in follow-up. When asked for tailored follow-up, professionals indicate more factors for increased follow-up (age<40 years, pT3-4 tumour, pN2-3, treatment related morbidity, and psychosocial support), than for reduced schedules (age >70 years and DCIS histology). Alternative forms of follow-up are not endorsed by >90% of respondents. Detection of a new primary tumour of the breast is considered the most important purpose of follow-up (98%), 57% still indicates detecting metastases as a goal.Conclusions: Professionals tend towards longer and more intensive follow-up than the current guideline for a large group of patients. Limitations and developments in follow-up need to be considered to facilitate alternative follow-up strategies.3

show abstract

Section: Professionals' Demographicssupporting

confidence: 66%

Professionals’ opinion on follow-up in breast cancer patients; perceived purpose and influence of patients’ risk factors

Hezewijk

Hille

Scholten

et al. 2011

European Journal of Surgical Oncology (EJSO)

View full text Add to dashboard Cite

show abstract

“…11,15 CEA is cheap and available, but is irregularly used in follow-up and has poor protocol adherence. 16,17 No studies of serial CEA measurements and imaging steps in response to significant CEA rise, with special attention to reasonable sensitivity in combination with good specificity, have been performed so far.…”

Section: Introductionmentioning

confidence: 98%

Intensified follow-up in colorectal cancer patients using frequent Carcino-Embryonic Antigen (CEA) measurements and CEA-triggered imaging: Results of the randomized “CEAwatch” trial

Verberne

Zhan

Heuvel

et al. 2015

European Journal of Surgical Oncology (EJSO)

Self Cite

View full text Add to dashboard Cite

show abstract

“…The ideal follow-up for CRC patients has not yet been settled, although there are national guidelines (http://www.oncoline.nl) [2]. Since the value of physical examination in finding recurrent disease is low, there can be a benefit in reducing outpatient visits.…”

Section: Introductionmentioning

confidence: 99%

Evaluation of the use of decision-support software in carcino-embryonic antigen (CEA)-based follow-up of patients with colorectal cancer

Verberne

Nijboer

Bock

et al. 2012

BMC Med Inform Decis Mak

View full text Add to dashboard Cite

BackgroundThe present paper is a first evaluation of the use of "CEAwatch", a clinical support software system for surgeons for the follow-up of colorectal cancer (CRC) patients. This system gathers Carcino-Embryonic Antigen (CEA) values and automatically returns a recommendation based on the latest values.MethodsConsecutive patients receiving follow-up care for CRC fulfilling our in- and exclusion criteria were identified to participate in this study. From August 2008, when the software was introduced, patients were asked to undergo the software-supported follow-up. Safety of the follow-up, experiences of working with the software, and technical issues were analyzed.Results245 patients were identified. The software-supported group contained 184 patients; the control group contained 61 patients. The software was safe in finding the same amount of recurrent disease with fewer outpatient visits, and revealed few technical problems. Clinicians experienced a decrease in follow-up workload of up to 50% with high adherence to the follow-up scheme.ConclusionCEAwatch is an efficient software tool helping clinicians working with large numbers of follow-up patients. The number of outpatient visits can safely be reduced, thus significantly decreasing workload for clinicians.

show abstract

Results of a national survey among Dutch surgeons treating patients with colorectal carcinoma. Current opinion about follow‐up, treatment of metastasis, and reasons to revise follow‐up practice

Cited by 29 publications

References 41 publications

Professionals’ opinion on follow-up in breast cancer patients; perceived purpose and influence of patients’ risk factors

Professionals’ opinion on follow-up in breast cancer patients; perceived purpose and influence of patients’ risk factors

Intensified follow-up in colorectal cancer patients using frequent Carcino-Embryonic Antigen (CEA) measurements and CEA-triggered imaging: Results of the randomized “CEAwatch” trial

Evaluation of the use of decision-support software in carcino-embryonic antigen (CEA)-based follow-up of patients with colorectal cancer

Contact Info

Product

Resources

About